NCT06425861View on ClinicalTrials.gov

A First in Human Trial Evaluating THB335 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

March 15, 2025

Study Completion Date

March 15, 2025

Conditions
Healthy
Interventions
DRUG

THB335 single dose

Single dose as oral capsule

DRUG

Single dose placebo

Single dose as oral capsule

DRUG

THB335 fasted/fed

Single dose fasted and fed as oral capsule

DRUG

Placebo fasted/fed

Single dose fasted and fed as oral capsule

DRUG

THB335 multiple dose

Multiple ascending doses oral capsule

DRUG

Multiple dose placebo

Multiple doses oral capsule

Trial Locations (1)

33143

RECRUITING

QPS Miami, Miami

All Listed Sponsors
lead

Third Harmonic Bio, Inc.

INDUSTRY